NewsBytes
    Hindi Tamil Telugu
    More
    In the news
    Narendra Modi
    Amit Shah
    Box Office Collection
    Bharatiya Janata Party (BJP)
    OTT releases
    Hindi Tamil Telugu
    NewsBytes
    User Placeholder

    Hi,

    Logout

    India
    Business
    World
    Politics
    Sports
    Technology
    Entertainment
    Auto
    Lifestyle
    Inspirational
    Career
    Bengaluru
    Delhi
    Mumbai

    Download Android App

    Follow us on
    • Facebook
    • Twitter
    • Linkedin
    Home / News / India News / 35 lakh doses of J&J COVID-19 vaccine reach Kasauli lab
    Next Article
    35 lakh doses of J&J COVID-19 vaccine reach Kasauli lab
    Johnson & Johnson’s COVID-19 vaccine, Janssen, is being manufactured in collaboration with Hyderabad-based Biological E.

    35 lakh doses of J&J COVID-19 vaccine reach Kasauli lab

    By Siddhant Pandey
    Sep 15, 2021
    09:40 am

    What's the story

    Around 35 lakh doses of the COVID-19 vaccine developed by United States pharma giant Johnson & Johnson have reportedly reached the apex vaccine testing laboratory in Kasauli, Himachal Pradesh.

    The single-shot vaccine, called Janssen, has been found to be 85.4% against severe disease.

    India had approved the vaccine in August and it is being manufactured in collaboration with Hyderabad-based Biological E.

    Details

    Vaccine to be tested on 100 participants

    An official of the Union Health Ministry told CNN-News18 that 35 lakh doses have been sent to the Kasauli lab in the first batch for testing.

    "It will take around two to three weeks for testing at CDL (Central Drugs Laboratory)," added the official.

    Thereafter, the COVID-19 vaccine will be tested on 100 participants for seven days in a fast-tracked model.

    Information

    'After testing on 100 people, national rollout will be approved'

    The official said, "After completing the testing, the vaccine will be administered to 100 participants first, as mentioned in the rules for foreign vaccines. After analyzing those 100 participants for seven days, the regulator will approve the vaccine for national rollout."

    Background

    Vaccine granted EUA in August; 6 shots approved so far

    Earlier, it was reported that Janssen will be rolled out by October.

    The vaccine had been granted Emergency Use Approval (EUA) by the Drug Controller General of India (DCGI) on August 7, making it the fifth COVID-19 vaccine approved in India.

    Overall, six vaccines have been approved for use in India so far: Covishield, COVAXIN, Sputnik V, Moderna, Janssen, and Zydus Cadila's ZyCoV-D.

    Rules

    India had fast-tracked approvals for certain foreign vaccines

    The Union Health Ministry had revised its rules on April 13, allowing fast-tracked approval for foreign COVID-19 vaccines that have been granted emergency approval for restricted use by the US-FDA, the EMA, the UK-MHRA, the PMDA-Japan, or the World Health Organization.

    These vaccines will be granted approval after bridging trials on 100 beneficiaries for seven days instead of full-fledged local clinical trials.

    Vaccine

    What is the J&J vaccine?

    J&J's vaccine uses a single shot, which has a clear advantage in mass vaccinations among hard-to-reach populations, such as homeless people.

    Janssen—which can be stored at 2-8°C—is 85.4% effective in preventing severe disease and 93.1% effective in preventing hospitalization.

    Earlier, there had been concerns about a blood clot risk, which had prompted the European Medicines Agency to suggest listing it as a rare side-effect.

    Facebook
    Whatsapp
    Twitter
    Linkedin
    Related News
    Latest
    Johnson & Johnson
    COVID-19 Vaccine
    Biological E

    Latest

    'India already has 140cr…': SC rejects Sri Lankan's refuge plea  Madras High Court
    Decoding the 170-plus partnerships against Delhi Capitals in IPL Indian Premier League (IPL)
    Microsoft Build 2025 starts today: How to watch the keynote Microsoft
    Xiaomi to take on Tesla's best-selling EV with YU7 SUV Tesla

    Johnson & Johnson

    Mumbai battles tuberculosis: 50,000 cases reported in 3 years Mumbai
    Conservative attacks on #MarchForOurLives student leaders turn personal X
    Telangana attracts over Rs. 10,000cr in Life Sciences in 4yrs Telangana
    Johnson & Johnson claims Indian victims' pleas are 'unreasonable' United States of America

    COVID-19 Vaccine

    Fully-vaccinated Mumbaikars can travel in local trains from August 15 Mumbai
    India's COVID-19 situation is getting worse, says top scientist India
    Zydus Cadila COVID-19 vaccine may get emergency nod this week Mansukh Mandaviya
    Mumbai: Stations to issue QR code-based passes for fully-vaccinated citizens Mumbai

    Biological E

    Modi to chair all-party meet to review COVID-19 situation Friday Narendra Modi
    India's neighbors train experts for clinical trials of COVID-19 vaccine Sri Lanka
    How Biological E's coronavirus vaccine could be a potential gamechanger India
    Phase 2/3 trials of Corbevax on 5-18 age group permitted Coronavirus
    Indian Premier League (IPL) Celebrity Hollywood Bollywood UEFA Champions League Tennis Football Smartphones Cryptocurrency Upcoming Movies Premier League Cricket News Latest automobiles Latest Cars Upcoming Cars Latest Bikes Upcoming Tablets
    About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive Download DevBytes Find Cricket Statistics
    Follow us on
    Facebook Twitter Linkedin
    All rights reserved © NewsBytes 2025